{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T08:03:41Z","timestamp":1794470621905,"version":"4.9.1"},"publisher-location":"New York, NY","reference-count":60,"publisher":"Springer New York","isbn-type":[{"value":"9781493903627","type":"print"},{"value":"9781493903634","type":"electronic"}],"license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014]]},"DOI":"10.1007\/978-1-4939-0363-4_15","type":"book-chapter","created":{"date-parts":[[2014,2,24]],"date-time":"2014-02-24T04:27:15Z","timestamp":1393216035000},"page":"233-247","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Intranasal Delivery of Chitosan\u2013siRNA Nanoparticle Formulation to the Brain"],"prefix":"10.1007","author":[{"given":"Meenakshi","family":"Malhotra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Tomaro-Duchesneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyamali","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satya","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,2,3]]},"reference":[{"key":"15_CR1","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1517\/17425240902758188","volume":"6","author":"TM Barchet","year":"2009","unstructured":"Barchet TM, Amiji MM (2009) Challenges and opportunities in CNS delivery of therapeutics for neurodegenerative diseases. Expert Opin Drug Deliv 6:211\u2013225","journal-title":"Expert Opin Drug Deliv"},{"key":"15_CR2","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.pneurobio.2008.12.002","volume":"87","author":"I Brasnjevic","year":"2009","unstructured":"Brasnjevic I, Steinbusch HWM, Schmitz C, Martinez-Martinez P (2009) Delivery of peptide and protein drugs over the blood\u2013brain barrier. Prog Neurobiol 87:212\u2013251","journal-title":"Prog Neurobiol"},{"key":"15_CR3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nrn1435","volume":"10","author":"PT Lansbury Jr","year":"2004","unstructured":"Lansbury PT Jr (2004) Back to the future: the \u2018old-fashioned\u2019 way to new medications for neurodegeneration. Nat Med 10:51\u201357","journal-title":"Nat Med"},{"key":"15_CR4","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1152\/physrev.00035.2003","volume":"84","author":"G Bazzoni","year":"2004","unstructured":"Bazzoni G, Dejana E (2004) Endothelial cell to cell junctions: molecular organization and role in vascular homeostasis. Physiol Rev 84:869\u2013901","journal-title":"Physiol Rev"},{"key":"15_CR5","first-page":"1129","volume":"38","author":"EA Neuwelt","year":"1996","unstructured":"Neuwelt EA, Kroll RA, Pagel MA et al (1996) Increasing volume of distribution to the brain with interstitial infusion: dose, rather than convection, might be the most important factor. Neurosurgery 38:1129\u20131145","journal-title":"Neurosurgery"},{"key":"15_CR6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0022-3565(25)30311-3","volume":"195","author":"RG Blasberg","year":"1975","unstructured":"Blasberg RG, Patlak C, Fenstermacher JD (1975) Intrathecal chemotherapy: brain tissue profiles after ventriculocisternal perfusion. J Pharmacol Exp Ther 195:73\u201383","journal-title":"J Pharmacol Exp Ther"},{"key":"15_CR7","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1227\/00006123-199505000-00012","volume":"36","author":"SE Doran","year":"1995","unstructured":"Doran SE, Ren XD, Betz AL et al (1995) Gene expression from recombinant viral vectors in the central nervous system after blood\u2013brain barrier disruption. Neurosurgery 36:965\u2013970","journal-title":"Neurosurgery"},{"key":"15_CR8","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1073\/pnas.91.6.2076","volume":"91","author":"RH Bobo","year":"1994","unstructured":"Bobo RH, Laske DW, Akbasak A et al (1994) Convection-enhanced delivery of macromolecules in the brain. Proc Natl Acad Sci U S A 91:2076\u20132082","journal-title":"Proc Natl Acad Sci U S A"},{"key":"15_CR9","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2165\/00126839-200708030-00001","volume":"8","author":"FW Merkus","year":"2007","unstructured":"Merkus FW, van den Berg MP (2007) Can nasal drug delivery bypass the blood-brain barrier?: questioning the direct transport theory. Drugs R D 8:133\u2013144","journal-title":"Drugs R D"},{"key":"15_CR10","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0168-3659(02)00363-2","volume":"87","author":"L Illum","year":"2003","unstructured":"Illum L (2003) Nasal drug delivery\u2014possibilities, problems and solutions. J Control Release 87:187\u2013198","journal-title":"J Control Release"},{"key":"15_CR11","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.neuroscience.2004.05.029","volume":"127","author":"RG Thorne","year":"2004","unstructured":"Thorne RG, Pronk GJ, Padmanabhan V et al (2004) Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration. Neuroscience 127:481\u2013496","journal-title":"Neuroscience"},{"key":"15_CR12","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1215\/15228517-2007-052","volume":"10","author":"R Hashizume","year":"2008","unstructured":"Hashizume R, Ozawa T, Gryaznov SM et al (2008) New therapeutic approach for brain tumors: intranasal delivery of telomerase inhibitor GRN163. Neuro Oncol 10:112\u2013120","journal-title":"Neuro Oncol"},{"key":"15_CR13","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1172\/JCI24761","volume":"115","author":"L Bertram","year":"2005","unstructured":"Bertram L, Tanzi RE (2005) The genetic epidemiology of neurodegenerative disease. J Clin Invest 115:1449\u20131457","journal-title":"J Clin Invest"},{"key":"15_CR14","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1517\/17460441.2011.555394","volume":"6","author":"M Malhotra","year":"2011","unstructured":"Malhotra M, Nambiar S, Swamy VR et al (2011) siRNA design strategies for effective targeting and gene silencing. Expert Opin Drug Discov 6:269\u2013289","journal-title":"Expert Opin Drug Discov"},{"key":"15_CR15","doi-asserted-by":"publisher","first-page":"4814","DOI":"10.1111\/j.1742-4658.2010.07904.x","volume":"277","author":"MS Shim","year":"2010","unstructured":"Shim MS, Kwon YJ (2010) Efficient and targeted delivery of siRNA in vivo. FEBS J 277:4814\u20134827","journal-title":"FEBS J"},{"key":"15_CR16","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1039\/b701169e","volume":"3","author":"P Lingor","year":"2007","unstructured":"Lingor P, Bahr M (2007) Targeting neurological disease with RNAi. Mol Biosyst 3:773\u2013780","journal-title":"Mol Biosyst"},{"key":"15_CR17","doi-asserted-by":"publisher","first-page":"3493","DOI":"10.1021\/nn102540y","volume":"5","author":"DJ Gary","year":"2011","unstructured":"Gary DJ, Lee H, Sharma R et al (2011) Influence of nano-carrier architecture on in vitro siRNA delivery performance and in vivo biodistribution: polyplexes vs. micelleplexes. ACS Nano 5:3493\u20133505","journal-title":"ACS Nano"},{"key":"15_CR18","first-page":"1373","volume":"7","author":"AP Perez","year":"2012","unstructured":"Perez AP, Mundi\u00f1a-Weilenmann C, Romero EL et al (2012) Increased brain radioactivity by intranasal 32P-labeled siRNA dendriplexes within in situ-forming mucoadhesive gels. Int J Nanomedicine 7:1373\u20131385","journal-title":"Int J Nanomedicine"},{"key":"15_CR19","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nbt.1807","volume":"29","author":"L Alvarez-Erviti","year":"2011","unstructured":"Alvarez-Erviti L, Seow Y, Yin H et al (2011) Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol 29:341\u2013345","journal-title":"Nat Biotechnol"},{"key":"15_CR20","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1023\/A:1016418523014","volume":"19","author":"AM Dyer","year":"2002","unstructured":"Dyer AM, Hinchcliffe M, Watts P et al (2002) Nasal delivery of insulin using novel chitosan based formulations: a comparative study in two animal models between simple chitosan formulations and chitosan nanoparticles. Pharm Res 19:998\u20131008","journal-title":"Pharm Res"},{"key":"15_CR21","doi-asserted-by":"publisher","first-page":"3640","DOI":"10.1002\/jps.21674","volume":"98","author":"SRK Vaka","year":"2009","unstructured":"Vaka SRK, Sammeta SM, Day LB et al (2009) Delivery of nerve growth factor to brain via intranasal administration and enhancement of brain uptake. J Pharm Sci 98:3640\u20133646","journal-title":"J Pharm Sci"},{"key":"15_CR22","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3109\/10611860903483396","volume":"18","author":"AM Al-Ghananeem","year":"2010","unstructured":"Al-Ghananeem AM, Saeed H, Florence R et al (2010) Intranasal drug delivery of didanosine-loaded chitosan nanoparticles for brain targeting; an attractive route against infections caused by AIDS viruses. J Drug Target 18:381\u2013388","journal-title":"J Drug Target"},{"key":"15_CR23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.carbpol.2008.06.006","volume":"75","author":"Y Ming-Tsung","year":"2009","unstructured":"Ming-Tsung Y, Joan-Hwa Y, Jeng-Leun M (2009) Physicochemical characterization of chitin and chitosan from crab shells. Carbohydr Polym 75:15\u201321","journal-title":"Carbohydr Polym"},{"key":"15_CR24","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2174\/1876502500901010021","volume":"1","author":"NV Toan","year":"2009","unstructured":"Toan NV (2009) Production of chitin and chitosan from partially autolyzed shrimp shell materials. Open Biomater J 1:21\u201324","journal-title":"Open Biomater J"},{"key":"15_CR25","first-page":"2041","volume":"2013","author":"M Malhotra","year":"2013","unstructured":"Malhotra M, Tomaro-Duchesneau C, Saha S et al (2013) Development and characterization of chitosan-PEG-TAT nanoparticles for the intracellular delivery of siRNA. Int J Nanomedicine 2013:2041\u20132052","journal-title":"Int J Nanomedicine"},{"key":"15_CR26","first-page":"485","volume":"2011","author":"M Malhotra","year":"2011","unstructured":"Malhotra M, Lane C, Tomaro-Duchesneau C et al (2011) A novel scheme for synthesis of PEG-grafted-chitosan polymer for preparation of nanoparticles and other applications. Int J Nanomedicine 2011:485\u2013494","journal-title":"Int J Nanomedicine"},{"key":"15_CR27","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1021\/bm4000713","volume":"14","author":"I Richard","year":"2013","unstructured":"Richard I, Thibault M, De Crescenzo G et al (2013) Ionization behavior of chitosan and chitosan-DNA polyplexes indicate that chitosan has a similar capability to induce a proton-sponge effect as PEI. Biomacromolecules 14:1732\u20131740","journal-title":"Biomacromolecules"},{"key":"15_CR28","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ejpb.2003.09.006","volume":"57","author":"A Vila","year":"2004","unstructured":"Vila A, Sanchez A, Janes K et al (2004) Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice. Eur J Pharm Biopharm 57:123\u2013131","journal-title":"Eur J Pharm Biopharm"},{"key":"15_CR29","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.ymthe.2006.04.010","volume":"14","author":"KA Howard","year":"2006","unstructured":"Howard KA (2006) RNA interference in vitro and in vivo using a novel chitosan\/siRNA nanoparticle system. Mol Ther 14:476\u2013484","journal-title":"Mol Ther"},{"key":"15_CR30","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.addr.2004.09.004","volume":"57","author":"HO Alpar","year":"2005","unstructured":"Alpar HO, Somavarapu S, Atuah AN et al (2005) Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery. Adv Drug Deliv Rev 57:411\u2013430","journal-title":"Adv Drug Deliv Rev"},{"key":"15_CR31","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/1465-9921-7-112","volume":"7","author":"L Dong-Won","year":"2006","unstructured":"Dong-Won L, Shirley SA, Lockey RF et al (2006) Thiolated chitosan nanoparticles enhance anti-inflammatory effects of intranasally delivered theophylline. Respir Res 7:112","journal-title":"Respir Res"},{"key":"15_CR32","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1089\/10430340260185058","volume":"13","author":"M Kumar","year":"2002","unstructured":"Kumar M, Behera AK, Lockey RF et al (2002) Intranasal gene transfer by chitosan\u2013DNA nanospheres protects BALB\/c mice against acute respiratory syncytial virus infection. Hum Gene Ther 13:1415\u20131425","journal-title":"Hum Gene Ther"},{"key":"15_CR33","first-page":"1973","volume":"18","author":"X Zhu","year":"2012","unstructured":"Zhu X, Su M, Tang S et al (2012) Synthesis of thiolated chitosan and preparation nanoparticles with sodium alginate for ocular drug delivery. Mol Vis 18:1973\u20131982","journal-title":"Mol Vis"},{"key":"15_CR34","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1016\/j.biomaterials.2012.10.013","volume":"34","author":"M Malhotra","year":"2013","unstructured":"Malhotra M, Tomaro-Duchesneau C, Prakash S (2013) Synthesis of TAT peptide tagged PEGylated chitosan nanoparticles for siRNA delivery targeting neurodegenerative diseases. Biomaterials 34:1270\u20131280","journal-title":"Biomaterials"},{"key":"15_CR35","doi-asserted-by":"crossref","unstructured":"Malhotra M, Tomaro-Duchesneau C, Saha S et al (2013) Intranasal siRNA delivery to the brain by TAT\/MGF tagged PEGylated chitosan nanoparticles. J Pharm 2013: Article ID:812387, 10 pages. http:\/\/www.hindawi.com\/journals\/jphar\/2013\/812387\/","DOI":"10.1155\/2013\/812387"},{"key":"15_CR36","doi-asserted-by":"crossref","unstructured":"Malhotra M, Tomaro-Duchesneau C, Saha S et al (2013) Systemic siRNA delivery via peptide tagged polymeric nanoparticles, targeting PLK1 gene in a mouse xenograft model of colorectal cancer. Int J Biomater 2013, Article ID: 252531, 13 pages. http:\/\/www.hindawi.com\/journals\/ijbm\/2013\/252531\/","DOI":"10.1155\/2013\/252531"},{"key":"15_CR37","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1080\/03639040802526789","volume":"35","author":"M Malhotra","year":"2009","unstructured":"Malhotra M, Kulamarva A, Sebak S et al (2009) Ultra-small nanoparticles of low molecular weight chitosan as an efficient delivery system targeting neuronal cells. Drug Dev Ind Pharm 35:719\u2013726","journal-title":"Drug Dev Ind Pharm"},{"key":"15_CR38","doi-asserted-by":"publisher","first-page":"3482","DOI":"10.1016\/j.biomaterials.2006.01.038","volume":"27","author":"X Gao","year":"2006","unstructured":"Gao X, Tao W, Lu W et al (2006) Lectin-conjugated PEG\u2013PLA nanoparticles: preparation and brain delivery after intranasal administration. Biomaterials 27:3482\u20133490","journal-title":"Biomaterials"},{"key":"15_CR39","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.ejpb.2008.07.005","volume":"70","author":"X Wang","year":"2008","unstructured":"Wang X, Chi N, Tang X (2008) Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting. Eur J Pharm Biopharm 70:735\u2013740","journal-title":"Eur J Pharm Biopharm"},{"key":"15_CR40","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jconrel.2007.05.026","volume":"121","author":"X Gao","year":"2007","unstructured":"Gao X, Wu B, Zhang Q et al (2007) Brain delivery of vasoactive intestinal peptide enhanced with the nanoparticles conjugated with wheat germ agglutinin following intranasal administration. J Control Release 121:156\u2013167","journal-title":"J Control Release"},{"key":"15_CR41","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.ijpharm.2007.03.039","volume":"340","author":"X Gao","year":"2007","unstructured":"Gao X, Chen J, Tao W et al (2007) UEA I-bearing nanoparticles for brain delivery following intranasal administration. Int J Pharm 340:207\u2013215","journal-title":"Int J Pharm"},{"key":"15_CR42","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.toxlet.2008.10.001","volume":"183","author":"J Wang","year":"2008","unstructured":"Wang J, Chen C, Liu Y et al (2008) Potential neurological lesion after nasal instillation of TiO2 nanoparticles in the anatase and rutile crystal phases. Toxicol Lett 183:72\u201380","journal-title":"Toxicol Lett"},{"key":"15_CR43","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.tox.2008.09.014","volume":"254","author":"J Wang","year":"2008","unstructured":"Wang J, Liu Y, Jiao F (2008) Time-dependent translocation and potential impairment on central nervous system by intranasally instilled TiO2 nanoparticles. Toxicology 254:82\u201390","journal-title":"Toxicology"},{"key":"15_CR44","doi-asserted-by":"publisher","first-page":"9888","DOI":"10.1016\/j.biomaterials.2011.09.004","volume":"32","author":"H Xia","year":"2011","unstructured":"Xia H, Gao X, Gua G et al (2011) Low molecular weight protamine-functionalized nanoparticles for drug delivery to the brain after intranasal administration. Biomaterials 32:9888\u20139898","journal-title":"Biomaterials"},{"key":"15_CR45","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1021\/bc8002698","volume":"19","author":"X Gao","year":"2008","unstructured":"Gao X, Chen J, Chen J et al (2008) Quantum dots bearing lectin-functionalized nanoparticles as a platform for in vivo brain imaging. Bioconjug Chem 19:2189\u20132195","journal-title":"Bioconjug Chem"},{"key":"15_CR46","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jconrel.2011.02.022","volume":"151","author":"Z Wen","year":"2011","unstructured":"Wen Z, Yan Z, Hu K et al (2011) Odorranalectin-conjugated nanoparticles: preparation, brain delivery and pharmacodynamic study on Parkinson\u2019s disease following intranasal administration. J Control Release 151:131\u2013138","journal-title":"J Control Release"},{"key":"15_CR47","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1080\/10611860600721051","volume":"14","author":"Q Zhang","year":"2006","unstructured":"Zhang Q, Zha L, Zhang Y et al (2006) The brain targeting efficiency following nasally applied MPEG-PLA nanoparticles in rats. J Drug Target 14:281\u2013290","journal-title":"J Drug Target"},{"key":"15_CR48","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/bdd.621","volume":"29","author":"Q Cheng","year":"2008","unstructured":"Cheng Q, Feng J, Chen J et al (2008) Brain transport of neurotoxin-I with PLA nanoparticles through intranasal administration in rats: a microdialysis study. Biopharm Drug Dispos 29:431\u2013439","journal-title":"Biopharm Drug Dispos"},{"key":"15_CR49","doi-asserted-by":"publisher","first-page":"5705","DOI":"10.2147\/IJN.S35329","volume":"2012","author":"S Alam","year":"2012","unstructured":"Alam S, Khan ZI, Mustafa G et al (2012) Development and evaluation of thymoquinone-encapsulated chitosan nanoparticles for nose-to-brain targeting: a pharmacoscintigraphic study. Int J Nanomedicine 2012:5705\u20135718","journal-title":"Int J Nanomedicine"},{"key":"15_CR50","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.ejps.2012.12.007","volume":"48","author":"S Md","year":"2012","unstructured":"Md S, Khan RA, Mustafa G et al (2012) Bromocriptine loaded chitosan nanoparticles intended for direct nose to brain delivery: pharmacodynamic, pharmacokinetic and scintigraphy study in mice model. Eur J Pharm Sci 48:393\u2013405","journal-title":"Eur J Pharm Sci"},{"key":"15_CR51","doi-asserted-by":"publisher","DOI":"10.3109\/03639045.2013.789051","author":"S Sharma","year":"2013","unstructured":"Sharma S, Lohan S, Murthy RS (2013) Formulation and characterization of intranasal mucoadhesive nanoparticulates and thermo-reversible gel of levodopa for brain delivery. Drug Dev Ind Pharm. doi:10.3109\/03639045.2013.789051","journal-title":"Drug Dev Ind Pharm"},{"key":"15_CR52","doi-asserted-by":"publisher","DOI":"10.1007\/s00709-013-0516-9","author":"N Ahmad","year":"2013","unstructured":"Ahmad N, Umar S, Ashafaq M et al (2013) A comparative study of PNIPAM nanoparticles of curcumin, demethoxycurcumin, and bisdemethoxycurcumin and their effects on oxidative stress markers in experimental stroke. Protoplasma. doi:10.1007\/s00709-013-0516-9","journal-title":"Protoplasma"},{"key":"15_CR53","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3109\/1061186X.2012.725405","volume":"21","author":"SR Vaka","year":"2013","unstructured":"Vaka SR, Shivakumar HN, Repka MA et al (2013) Formulation and evaluation of carnosic acid nanoparticulate system for upregulation of neurotrophins in the brain upon intranasal administration. J Drug Target 21:44\u201353","journal-title":"J Drug Target"},{"key":"15_CR54","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ejps.2012.04.013","volume":"47","author":"M Fazil","year":"2012","unstructured":"Fazil M, Md S, Haque S, Kumar M et al (2012) Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting. Eur J Pharm Sci 47:6\u201315","journal-title":"Eur J Pharm Sci"},{"key":"15_CR55","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1007\/s10856-012-4702-7","volume":"23","author":"AS Joshi","year":"2012","unstructured":"Joshi AS, Patel HS, Belgamwar VS (2012) Solid lipid nanoparticles of ondansetron HCl for intranasal delivery: development, optimization and evaluation. J Mater Sci Mater Med 23:2163\u20132175","journal-title":"J Mater Sci Mater Med"},{"key":"15_CR56","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.neuro.2012.09.006","volume":"34","author":"J Wu","year":"2013","unstructured":"Wu J, Ding T, Sun J (2013) Neurotoxic potential of iron oxide nanoparticles in the rat brain striatum and hippocampus. Neurotoxicology 34:243\u2013253","journal-title":"Neurotoxicology"},{"key":"15_CR57","doi-asserted-by":"publisher","first-page":"3870","DOI":"10.1016\/j.biomaterials.2013.02.003","volume":"34","author":"Z Liu","year":"2013","unstructured":"Liu Z, Jiang M, Kang T et al (2013) Lactoferrin-modified PEG-co-PCL nanoparticles for enhanced brain delivery of NAP peptide following intranasal administration. Biomaterials 34:3870\u20133881","journal-title":"Biomaterials"},{"key":"15_CR58","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1002\/jps.21939","volume":"99","author":"MM Migliore","year":"2010","unstructured":"Migliore MM, Vyas TK, Campbell RB et al (2010) Brain delivery of proteins by the intranasal route of administration: a comparison of cationic liposomes versus aqueous solution formulations. J Pharm Sci 99:1745\u20131761","journal-title":"J Pharm Sci"},{"key":"15_CR59","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1038\/mt.2011.164","volume":"19","author":"X Zhuang","year":"2011","unstructured":"Zhuang X, Xiang X, Grizzle W et al (2011) Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain. Mol Ther 19:1769\u20131779","journal-title":"Mol Ther"},{"key":"15_CR60","first-page":"363","volume":"6","author":"S Eskandari","year":"2011","unstructured":"Eskandari S, Varshosaz J, Minaiyan M et al (2011) Brain delivery of valproic acid via intranasal administration of nanostructured lipid carriers: in vivo pharmacodynamic studies using rat electroshock model. Int J Nanomedicine 6:363\u2013371","journal-title":"Int J Nanomedicine"}],"container-title":["Methods in Molecular Biology","Drug Delivery System"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-0363-4_15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T18:34:11Z","timestamp":1746124451000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-4939-0363-4_15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"ISBN":["9781493903627","9781493903634"],"references-count":60,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-0363-4_15","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-1-4939-0363-4","asserted-by":"object"}]},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]},"assertion":[{"value":"3 February 2014","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}